ITOS - iTeos Therapeutics' (ITOS) CEO Michel Detheux on Q1 2021 Results - Earnings Call Transcript
iTeos Therapeutics, Inc. (ITOS) Q1 2021 Earnings Conference Call May 13, 2021 4:30 PM ET Company Participants Ryan Baker – Head of Investor Relations Michel Detheux – President and Chief Executive Officer Joe Lager – Chief Medical Officer Matthew Gall – Chief Financial Officer Conference Call Participants Chris Raymond – Piper Sandler Daina Graybosch – SVB Leerink Anupam Rama – JP Morgan Arthur He – HC Wainwright David Nierengarten – Wedbush Securities Presentation Operator Good afternoon and welcome to the iTeos Therapeutics First Quarter 2021 Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded at the company's request. Now I'd like to turn over to Ryan Baker, Head of Investor Relations at iTeos. Sir, please proceed. Ryan Baker Thank you for joining us
For further details see:
iTeos Therapeutics' (ITOS) CEO Michel Detheux on Q1 2021 Results - Earnings Call Transcript